Related Experiment Video
Updated: Jul 5, 2025
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
10.0K
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in
Shaji K Kumar1, Natalie S Callander2, Kehinde Adekola3
1Mayo Clinic Comprehensive Cancer Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|January 20, 2024
Abstract:
The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of response to treatment, and follow-up of both newly diagnosed and previously treated WM/LPL.
